设为首页         

资讯内容 Content

[ESC2009]单片复方制剂(SPC)倍博特在高血压治疗中的应用和优势--Weir教授专访
国际循环网版权所有,谢绝任何形式转载,侵犯版权者必予法律追究。

 编辑:国际循环网 时间:2009/9/3 18:26:00    加入收藏
 关键字:单片复方制剂 高血压治疗 倍博特 阿利吉仑 


International Circulation:  This valsartan amlodipine combination in a single pill(Exforge®)had been approved as a first line medication in the USA. What do you consider the position and the current clinical usage in US?

《国际循环》:在美国这种缬沙坦氨氯地平单片联合药物(Exforge®)已经被批准为一线药物。您如何评价其在美国的地位和目前的临床应用?

Professor Weir:  Well there is more and more use of single pill combinations in large part because physicians are experienced with them.  The guidelines have been suggesting them for a number of years now and of course, newer FDA approvals for the use of single pills for people with moderate to severe hypertension.  So I think it is a combination of these events and of course physician knowledge that some patients do benefit from more prompt attention and lower blood pres

上一页  [1]  [2]  [3]  [4]  [5]  [6]  

用户:zhengzilan 时间:2013/6/16 19:24:08
非常好,谢谢了!

注册

网友评论仅供其表达个人看法,并不表明国际循环同意其观点或证实其描述。 发表评论需登陆

 
关于本站 | 设为首页 | 加入收藏 | 站长邮箱 | 友情链接 | 版权申明

国际循环 版权所有  2008-2010 icirculation.com  All Rights Reserved